- Home
- ISPR vs PROF Comparison
ISPR vs PROF Comparison
Compare ISPR & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPR
- PROF
- Stock Information
- Founded
- ISPR 2010
- PROF N/A
- Country
- ISPR United States
- PROF Canada
- Employees
- ISPR N/A
- PROF N/A
- Industry
- ISPR Medicinal Chemicals and Botanical Products
- PROF Medical/Dental Instruments
- Sector
- ISPR Health Care
- PROF Health Care
- Exchange
- ISPR Nasdaq
- PROF Nasdaq
- Market Cap
- ISPR 126.0M
- PROF 130.4M
- IPO Year
- ISPR 2023
- PROF N/A
- Fundamental
- Price
- ISPR $2.26
- PROF $6.13
- Analyst Decision
- ISPR Strong Buy
- PROF Strong Buy
- Analyst Count
- ISPR 1
- PROF 1
- Target Price
- ISPR $7.50
- PROF $11.00
- AVG Volume (30 Days)
- ISPR 45.3K
- PROF 81.6K
- Earning Date
- ISPR 11-12-2025
- PROF 11-13-2025
- Dividend Yield
- ISPR N/A
- PROF N/A
- EPS Growth
- ISPR N/A
- PROF N/A
- EPS
- ISPR N/A
- PROF N/A
- Revenue
- ISPR $127,494,304.00
- PROF $11,840,000.00
- Revenue This Year
- ISPR $60.96
- PROF $60.07
- Revenue Next Year
- ISPR $23.96
- PROF $121.80
- P/E Ratio
- ISPR N/A
- PROF N/A
- Revenue Growth
- ISPR N/A
- PROF 59.81
- 52 Week Low
- ISPR $2.06
- PROF $3.76
- 52 Week High
- ISPR $7.47
- PROF $9.17
- Technical
- Relative Strength Index (RSI)
- ISPR 42.61
- PROF 60.63
- Support Level
- ISPR $2.31
- PROF $5.21
- Resistance Level
- ISPR $2.65
- PROF $5.87
- Average True Range (ATR)
- ISPR 0.18
- PROF 0.38
- MACD
- ISPR -0.00
- PROF -0.01
- Stochastic Oscillator
- ISPR 33.90
- PROF 73.02
About ISPR Ispire Technology Inc.
Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping products in the United States, Europe, Canada, and South Africa. Geographically, the company generates the majority of its revenue from Europe.
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.